Form 8-K - Current report:
SEC Accession No. 0001641172-25-020295
Filing Date
2025-07-21
Accepted
2025-07-18 17:48:56
Documents
12
Period of Report
2025-07-18
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 38551
  Complete submission text file 0001641172-25-020295.txt   205281

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE dare-20250718.xsd EX-101.SCH 3032
3 XBRL LABEL FILE dare-20250718_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE dare-20250718_pre.xml EX-101.PRE 22370
14 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3658
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

EIN.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36395 | Film No.: 251135332
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)